Alternate-Day Buprenorphine. Phase V - 6

Completed · Phase 1

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to evaluate buprenorphine blockade challenge.

Key facts

Study ID

NCT00000224

Run by

National Institute on Drug Abuse (NIDA)

People needed

0

Starts

1993-02-01

Last updated by the study team

2005-06-24

Who can join

Age: 30 and older, up to 49. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Treatment Research Center — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.